Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells

Autores
Reiter, Russel; Sharma, Ramaswamy; Rosales Corral, Sergio; Manucha, Walter Ariel Fernando; Almeida Chuffa, Luiz Gustavo de; Pires de Campos Zuccari, Debora Aparecida
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Melatonin is synthesized in the pineal gland at night. Since melatonin is produced in the mitochondria of all other cells in a non-circadian manner, the amount synthesized by the pineal gland is less than 5% of the total. Melatonin produced in mitochondria influences glucose metabolism in all cells. Many pathological cells adopt aerobic glycolysis (Warburg effect) in which pyruvate is excluded from the mitochondria and remains in the cytosol where it is metabolized to lactate. The entrance of pyruvate into the mitochondria of healthy cells allows it to be irreversibly decarboxylated by pyruvate dehydrogenase (PDH) to acetyl coenzyme A (acetyl-CoA). The exclusion of pyruvate from the mitochondria in pathological cells prevents the generation of acetyl-CoA from pyruvate. This is relevant to mitochondrial melatonin production, as acetyl-CoA is a required co-substrate/co-factor for melatonin synthesis. When PDH is inhibited during aerobic glycolysis or during intracellular hypoxia, the deficiency of acetyl-CoA likely prevents mitochondrial melatonin synthesis. When cells experiencing aerobic glycolysis or hypoxia with a diminished level of acetyl-CoA are supplemented with melatonin or receive it from another endogenous source (pineal-derived), pathological cells convert to a more normal phenotype and support the transport of pyruvate into the mitochondria, thereby re-establishing a healthier mitochondrial metabolic physiology.
Fil: Reiter, Russel. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados Unidos
Fil: Sharma, Ramaswamy. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados Unidos
Fil: Rosales Corral, Sergio. Instituto Mexicano del Seguro Social; México
Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Almeida Chuffa, Luiz Gustavo de. Institute of Biosciences of Botucatu; Brasil
Fil: Pires de Campos Zuccari, Debora Aparecida. Faculdade de Medicina de Sao Jose Do Rio Preto; Brasil
Materia
AEROBIC GLYCOLYSIS
CANCER
DISEASED CELLS
MELATONIN
MITOCHONDRIAL METABOLISM
WARBURG EFFECT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/173275

id CONICETDig_fda87c68837094c659973e50c708a6d1
oai_identifier_str oai:ri.conicet.gov.ar:11336/173275
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cellsReiter, RusselSharma, RamaswamyRosales Corral, SergioManucha, Walter Ariel FernandoAlmeida Chuffa, Luiz Gustavo dePires de Campos Zuccari, Debora AparecidaAEROBIC GLYCOLYSISCANCERDISEASED CELLSMELATONINMITOCHONDRIAL METABOLISMWARBURG EFFECThttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Melatonin is synthesized in the pineal gland at night. Since melatonin is produced in the mitochondria of all other cells in a non-circadian manner, the amount synthesized by the pineal gland is less than 5% of the total. Melatonin produced in mitochondria influences glucose metabolism in all cells. Many pathological cells adopt aerobic glycolysis (Warburg effect) in which pyruvate is excluded from the mitochondria and remains in the cytosol where it is metabolized to lactate. The entrance of pyruvate into the mitochondria of healthy cells allows it to be irreversibly decarboxylated by pyruvate dehydrogenase (PDH) to acetyl coenzyme A (acetyl-CoA). The exclusion of pyruvate from the mitochondria in pathological cells prevents the generation of acetyl-CoA from pyruvate. This is relevant to mitochondrial melatonin production, as acetyl-CoA is a required co-substrate/co-factor for melatonin synthesis. When PDH is inhibited during aerobic glycolysis or during intracellular hypoxia, the deficiency of acetyl-CoA likely prevents mitochondrial melatonin synthesis. When cells experiencing aerobic glycolysis or hypoxia with a diminished level of acetyl-CoA are supplemented with melatonin or receive it from another endogenous source (pineal-derived), pathological cells convert to a more normal phenotype and support the transport of pyruvate into the mitochondria, thereby re-establishing a healthier mitochondrial metabolic physiology.Fil: Reiter, Russel. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados UnidosFil: Sharma, Ramaswamy. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados UnidosFil: Rosales Corral, Sergio. Instituto Mexicano del Seguro Social; MéxicoFil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; ArgentinaFil: Almeida Chuffa, Luiz Gustavo de. Institute of Biosciences of Botucatu; BrasilFil: Pires de Campos Zuccari, Debora Aparecida. Faculdade de Medicina de Sao Jose Do Rio Preto; BrasilMultidisciplinary Digital Publishing Institute2021-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/173275Reiter, Russel; Sharma, Ramaswamy; Rosales Corral, Sergio; Manucha, Walter Ariel Fernando; Almeida Chuffa, Luiz Gustavo de; et al.; Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells; Multidisciplinary Digital Publishing Institute; International Journal of Molecular Sciences; 22; 22; 11-2021; 1-221422-0067CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1422-0067/22/22/12494info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms222212494info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:55:15Zoai:ri.conicet.gov.ar:11336/173275instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:55:15.588CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
title Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
spellingShingle Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
Reiter, Russel
AEROBIC GLYCOLYSIS
CANCER
DISEASED CELLS
MELATONIN
MITOCHONDRIAL METABOLISM
WARBURG EFFECT
title_short Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
title_full Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
title_fullStr Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
title_full_unstemmed Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
title_sort Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells
dc.creator.none.fl_str_mv Reiter, Russel
Sharma, Ramaswamy
Rosales Corral, Sergio
Manucha, Walter Ariel Fernando
Almeida Chuffa, Luiz Gustavo de
Pires de Campos Zuccari, Debora Aparecida
author Reiter, Russel
author_facet Reiter, Russel
Sharma, Ramaswamy
Rosales Corral, Sergio
Manucha, Walter Ariel Fernando
Almeida Chuffa, Luiz Gustavo de
Pires de Campos Zuccari, Debora Aparecida
author_role author
author2 Sharma, Ramaswamy
Rosales Corral, Sergio
Manucha, Walter Ariel Fernando
Almeida Chuffa, Luiz Gustavo de
Pires de Campos Zuccari, Debora Aparecida
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv AEROBIC GLYCOLYSIS
CANCER
DISEASED CELLS
MELATONIN
MITOCHONDRIAL METABOLISM
WARBURG EFFECT
topic AEROBIC GLYCOLYSIS
CANCER
DISEASED CELLS
MELATONIN
MITOCHONDRIAL METABOLISM
WARBURG EFFECT
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Melatonin is synthesized in the pineal gland at night. Since melatonin is produced in the mitochondria of all other cells in a non-circadian manner, the amount synthesized by the pineal gland is less than 5% of the total. Melatonin produced in mitochondria influences glucose metabolism in all cells. Many pathological cells adopt aerobic glycolysis (Warburg effect) in which pyruvate is excluded from the mitochondria and remains in the cytosol where it is metabolized to lactate. The entrance of pyruvate into the mitochondria of healthy cells allows it to be irreversibly decarboxylated by pyruvate dehydrogenase (PDH) to acetyl coenzyme A (acetyl-CoA). The exclusion of pyruvate from the mitochondria in pathological cells prevents the generation of acetyl-CoA from pyruvate. This is relevant to mitochondrial melatonin production, as acetyl-CoA is a required co-substrate/co-factor for melatonin synthesis. When PDH is inhibited during aerobic glycolysis or during intracellular hypoxia, the deficiency of acetyl-CoA likely prevents mitochondrial melatonin synthesis. When cells experiencing aerobic glycolysis or hypoxia with a diminished level of acetyl-CoA are supplemented with melatonin or receive it from another endogenous source (pineal-derived), pathological cells convert to a more normal phenotype and support the transport of pyruvate into the mitochondria, thereby re-establishing a healthier mitochondrial metabolic physiology.
Fil: Reiter, Russel. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados Unidos
Fil: Sharma, Ramaswamy. University Of Texas At San Antonio. University Of Texas Health Science Center At San Antonio (ut Health San Antonio); Estados Unidos
Fil: Rosales Corral, Sergio. Instituto Mexicano del Seguro Social; México
Fil: Manucha, Walter Ariel Fernando. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto de Medicina y Biología Experimental de Cuyo; Argentina
Fil: Almeida Chuffa, Luiz Gustavo de. Institute of Biosciences of Botucatu; Brasil
Fil: Pires de Campos Zuccari, Debora Aparecida. Faculdade de Medicina de Sao Jose Do Rio Preto; Brasil
description Melatonin is synthesized in the pineal gland at night. Since melatonin is produced in the mitochondria of all other cells in a non-circadian manner, the amount synthesized by the pineal gland is less than 5% of the total. Melatonin produced in mitochondria influences glucose metabolism in all cells. Many pathological cells adopt aerobic glycolysis (Warburg effect) in which pyruvate is excluded from the mitochondria and remains in the cytosol where it is metabolized to lactate. The entrance of pyruvate into the mitochondria of healthy cells allows it to be irreversibly decarboxylated by pyruvate dehydrogenase (PDH) to acetyl coenzyme A (acetyl-CoA). The exclusion of pyruvate from the mitochondria in pathological cells prevents the generation of acetyl-CoA from pyruvate. This is relevant to mitochondrial melatonin production, as acetyl-CoA is a required co-substrate/co-factor for melatonin synthesis. When PDH is inhibited during aerobic glycolysis or during intracellular hypoxia, the deficiency of acetyl-CoA likely prevents mitochondrial melatonin synthesis. When cells experiencing aerobic glycolysis or hypoxia with a diminished level of acetyl-CoA are supplemented with melatonin or receive it from another endogenous source (pineal-derived), pathological cells convert to a more normal phenotype and support the transport of pyruvate into the mitochondria, thereby re-establishing a healthier mitochondrial metabolic physiology.
publishDate 2021
dc.date.none.fl_str_mv 2021-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/173275
Reiter, Russel; Sharma, Ramaswamy; Rosales Corral, Sergio; Manucha, Walter Ariel Fernando; Almeida Chuffa, Luiz Gustavo de; et al.; Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells; Multidisciplinary Digital Publishing Institute; International Journal of Molecular Sciences; 22; 22; 11-2021; 1-22
1422-0067
CONICET Digital
CONICET
url http://hdl.handle.net/11336/173275
identifier_str_mv Reiter, Russel; Sharma, Ramaswamy; Rosales Corral, Sergio; Manucha, Walter Ariel Fernando; Almeida Chuffa, Luiz Gustavo de; et al.; Melatonin and pathological cell interactions: mitochondrial glucose processing in cancer cells; Multidisciplinary Digital Publishing Institute; International Journal of Molecular Sciences; 22; 22; 11-2021; 1-22
1422-0067
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/1422-0067/22/22/12494
info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms222212494
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613666904735744
score 13.070432